Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,556 | 204 | 97.5% |
| Education | $91.25 | 4 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $745.90 | 54 | $0 (2023) |
| Janssen Biotech, Inc. | $740.87 | 30 | $0 (2023) |
| ABBVIE INC. | $485.33 | 36 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $381.17 | 25 | $0 (2024) |
| GENZYME CORPORATION | $236.33 | 8 | $0 (2023) |
| Ardelyx, Inc. | $204.20 | 12 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $190.27 | 7 | $0 (2023) |
| QOL Medical, LLC | $173.45 | 7 | $0 (2022) |
| RedHill Biopharma Inc. | $167.67 | 9 | $0 (2023) |
| NESTLE HEALTHCARE NUTRITION INC. | $107.87 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $98.89 | 5 | IRONWOOD PHARMACEUTICALS, INC ($32.07) |
| 2023 | $1,634 | 87 | Janssen Biotech, Inc. ($554.88) |
| 2022 | $1,560 | 93 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($391.91) |
| 2021 | $353.91 | 23 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($164.55) |
All Payment Transactions
208 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $14.09 | General |
| Category: GI | ||||||
| 11/13/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $17.98 | General |
| Category: GI | ||||||
| 09/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $27.40 | General |
| Category: IMMUNOLOGY | ||||||
| 07/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/29/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/01/2023 | AbbVie Inc. | LINZESS (Drug), VIBERZI, CREON | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/29/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $10.86 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/10/2023 | Janssen Scientific Affairs, LLC | — | Food and Beverage | In-kind items and services | $15.97 | General |
| 11/10/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $2.92 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/09/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $122.78 | General |
| Category: Immunology | ||||||
| 11/09/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $28.61 | General |
| Category: Immunology | ||||||
| 11/09/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $14.16 | General |
| Category: GI | ||||||
| 11/03/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $10.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/01/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Gastroenterology | ||||||
| 10/31/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Immunology | ||||||
| 10/26/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $14.40 | General |
| Category: GI | ||||||
| 10/24/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: Gastroenterology | ||||||
| 10/24/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $4.40 | General |
| Category: Gastroenterology | ||||||
| 10/18/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $26.43 | General |
| Category: Immunology | ||||||
| 10/17/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $31.24 | General |
| Category: Immunology | ||||||
| 10/17/2023 | Evoke Pharma, Inc. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Gastroenterology | ||||||
| 10/13/2023 | Regeneron Healthcare Solutions, Inc. | — | Food and Beverage | In-kind items and services | $41.43 | General |
| 10/04/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $8.33 | General |
| Category: Gastroenterology | ||||||
| 09/29/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 196 | 279 | $249,000 | $28,498 |
| 2022 | 6 | 249 | 328 | $193,865 | $32,403 |
| 2021 | 3 | 49 | 54 | $13,675 | $5,167 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 91 | 166 | $41,500 | $15,235 | 36.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 48 | 55 | $82,500 | $5,437 | 6.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 39 | 40 | $80,000 | $4,295 | 5.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 18 | 18 | $45,000 | $3,530 | 7.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 106 | 178 | $40,525 | $15,802 | 39.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 51 | 52 | $63,000 | $6,276 | 10.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 47 | 49 | $44,100 | $5,078 | 11.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 11 | 12 | $39,600 | $2,335 | 5.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 26 | $3,440 | $1,616 | 47.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $3,200 | $1,295 | 40.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 25 | 30 | $4,950 | $3,036 | 61.3% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 11 | 11 | $7,425 | $1,205 | 16.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 13 | $1,300 | $925.60 | 71.2% |
About Dr. Michael Baird, M.D
Dr. Michael Baird, M.D is a Gastroenterology healthcare provider based in Sheboygan, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346252459.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Baird, M.D has received a total of $3,647 in payments from pharmaceutical and medical device companies, with $98.89 received in 2024. These payments were reported across 208 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,556).
As a Medicare-enrolled provider, Baird has provided services to 494 Medicare beneficiaries, totaling 661 services with total Medicare billing of $66,068. Data is available for 3 years (2021–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Sheboygan, WI
- Active Since 08/13/2006
- Last Updated 06/24/2010
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1346252459
Products in Payments
- STELARA (Biological) $509.22
- XIFAXAN (Drug) $475.86
- DUPIXENT (Biological) $385.17
- Linzess (Drug) $381.17
- LINZESS (Drug) $257.99
- REMICADE (Biological) $231.65
- IBSRELA (Drug) $204.20
- TRULANCE (Drug) $203.28
- SUCRAID (Drug) $173.45
- Talicia (Drug) $144.78
- ZENPEP (Drug) $107.87
- VIBERZI (Drug) $88.34
- CREON (Drug) $86.92
- RELISTOR (Drug) $66.76
- GIMOTI (Drug) $56.26
- DIFICID (Drug) $45.17
- RINVOQ (Biological) $27.40
- MAVYRET (Drug) $24.68
- Movantik (Drug) $22.89
- ENTYVIO (Biological) $20.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Sheboygan
Adebisi Alimi, M.d, M.D
Gastroenterology — Payments: $2,817
Marla Wolfert, M.d, M.D
Gastroenterology — Payments: $200.63
Patrick Regan, Md, MD
Gastroenterology — Payments: $102.00
Rana Sokhi, Md, MD
Gastroenterology — Payments: $16.11